Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Top ten research priorities for spinal cord injury: the methodology and results of a British priority setting partnership.
Novantrone (mitoxantrone HCl) Injection February 2009
Results from the 5-year, phase IV RENEW (Registry to Evaluate Novantrone Effects in Worsening Multiple Sclerosis) study.
Immune mechanisms of new therapeutic strategies in multiple sclerosis-A focus on alemtuzumab.
Incorporating Alcohol Pharmacotherapies Into Medical Practice
Glatiramer acetate after mitoxantrone induction improves MRI markers of lesion volume and permanent tissue injury in MS.
Genmab announces results of ofatumumab Phase II study in multiple sclerosis
Relationship between NMO-antibody and anti-MOG antibody in optic neuritis.
Effect of IFN β-1b on CXCR4-dependent chemotaxis in T cells from multiple sclerosis patients.
Intas launches biosimilar version of Rituximab
Opinion: Sex inclusion in basic research drives discovery.
Treatment of neurological injury with thymosin β4.
Rituximab (monoclonal anti-CD20 antibody): mechanisms of action and resistance.
Teva Announces U.S. Supreme Court Decision to Reverse Federal Circuit Court’s Judgment on COPAXONE® 20 mg/mL Case and Remand for Further Review
Monocytes P2X7 purinergic receptor is modulated by glatiramer acetate in multiple sclerosis.
Dilantin
Immunosuppressive properties of mesenchymal stem cells: advances and applications.
Breastfeeding and multiple sclerosis.
Combination therapy with mitoxantrone and plasma exchange in aggressive relapsing remitting multiple sclerosis: A preliminary clinical study.
Adaptive myelination from fish to man.
Once-daily AUBAGIO® delayed onset of clinically definite multiple sclerosis (MS) in TOPIC study
Regulation of prefrontal cortex myelination by the microbiota.
Immune competence after alemtuzumab treatment of multiple sclerosis.
A One Year Follow-Up Study of Natural Killer and Dendritic Cells Activities in Multiple Sclerosis Patients Receiving Glatiramer Acetate (GA).
Visualization of myelination in GFP-transgenic zebrafish.
Pages
« first
‹ previous
…
60
61
62
63
64
65
66
67
68
…
next ›
last »